Skip to main content
Equibles

UBS Group AG

Position in TEVA — Teva Pharmaceutical Industries Ltd

CIK 1610520 ZURICH, V8
Back to TEVA Full portfolio

Position in TEVA

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$72,505,400
+$15,963,625 QoQ
Shares Held
2,140,065
+14.0% QoQ
Ownership
0.184%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#55
of 675 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority Sole 81% Shared 0% None 19%

Common Shares in TEVA Over Time

Shares Held

Position Value (USD)

Derivatives in TEVA

reported options exposure · as of Jun 30, 2026
CallValue
$1,355,200
CallShares
40,000
PutValue
$0
PutShares
0

Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.

Position in Drug Manufacturers - Specialty & Generic

Healthcare · as of Jun 30, 2026

UBS Group AG holds $1,471,514,369 across 82 Drug Manufacturers - Specialty & Generic names. TEVA ranks #8 (4.9% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 ZTS
Zoetis Inc.
 3,643,241 $261,803,294
2 ELAN
Elanco Animal Health Inc
 9,910,822 $243,905,327
3 UTHR
UNITED THERAPEUTICS Corp
 220,616 $119,536,366
4 VTRS
Viatris Inc
 6,092,296 $96,745,659
5 LNTH
Lantheus Holdings, Inc.
 835,494 $92,689,703
6 HIMS
Hims & Hers Health, Inc.
 2,660,810 $92,250,281
7 NBIX
Neurocrine Biosciences Inc
 545,937 $92,012,220
8 TEVA
Teva Pharmaceutical Industries Ltd
This page 		2,140,065 $72,505,400

All Filings in TEVA

Export CSV
50 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $1,355,200 40,000
2026-06-30 $72,505,400 2,140,065
2026-03-31 $56,541,775 1,877,217
2026-03-31 $2,710,800 90,000
2026-03-31 $25,409,232 843,600
2025-12-31 $2,087,949 66,900
2025-12-31 $133,515,941 4,277,986
2025-12-31 $3,121,000 100,000
2025-09-30 $2,020,000 100,000
2025-09-30 $1,351,380 66,900
2025-09-30 $113,404,414 5,614,080
2025-06-30 $1,676,000 100,000
2025-06-30 $86,437,820 5,157,388
2025-06-30 $2,309,528 137,800
2025-03-31 $4,632,518 301,400
2025-03-31 $108,414,921 7,053,671
2024-12-31 $55,821,212 2,532,723
2024-12-31 $1,474,476 66,900
2024-09-30 $29,610,353 1,643,194
2024-09-30 $1,205,538 66,900
2024-06-30 $32,713,442 2,013,135
2024-06-30 $1,711,125 105,300
2024-03-31 $31,016,627 2,198,202
2024-03-31 $943,959 66,900
2023-12-31 $9,421,513 902,444
2023-09-30 $13,590,601 1,332,412
2023-06-30 $376,500 50,000
2023-06-30 $7,598,897 1,009,150
2023-03-31 $9,303,578 1,051,252
2023-03-31 $1,770,000 200,000
2022-12-31 $11,955,534 1,310,914
2022-12-31 $550,848 60,400
2022-09-30 $10,992,879 1,362,191
2022-09-30 $487,428 60,400
2022-06-30 $11,117,325 1,478,368
2022-06-30 $454,208 60,400
2022-03-31 $18,110,716 1,928,724
2021-12-31 $260,325 32,500
2021-12-31 $22,761,197 2,841,598
2021-09-30 $316,550 32,500
2021-09-30 $2,250,914 231,100
2021-09-30 $15,545,973 1,596,096
2021-06-30 $13,175,830 1,330,892
2021-06-30 $321,750 32,500
2021-06-30 $3,960,000 400,000
2021-03-31 $16,870,497 1,461,915
2021-03-31 $4,700,242 407,300
2021-03-31 $375,050 32,500
2020-12-31 $4,614,630 478,200
2020-12-31 $4,197,750 435,000